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Recent studies have elucidated the role of several pro-inflammatory factors as mediators
of inflammatory processes in the bovine endometrium. Only few studies, however, have
analyzed samples collected from different regions of the uterus of the same animal.
In this study, we tested the hypothesis that on a molecular level, clinical endometritis
is characterized by inflammatory responses spread over the entire endometrium.
Furthermore, we assume that subclinical endometritis is described by an inflammation of
local regions of the uterus. Therefore, the objective of this study was to assess the mRNA
expression of uterus-associated pro-inflammatory factors at five pre-defined endometrial
sites, i.e., corpus uteri, left horn base, left horn tip, right horn base, and right horn tip,
in cows with clinical and subclinical endometritis and in healthy controls. We analyzed
the mRNA expression of interleukin 1 alpha, interleukin 1 beta, C-X-C motif chemokine
ligand 8, prostaglandin-endoperoxide synthase 2, protein tyrosine phosphatase receptor
type C, carcinoembryonic antigen related cell adhesion molecule 1, and mucin 4 and 16.
Based on vaginoscopy and endometrial cytology (≥ 5% polymorphonuclear neutrophils)
between 28 to 34 days in milk, 18 Simmental cows were categorized in clinical
endometritis group (n = 7), subclinical endometritis group (n = 4), and healthy group
(n = 7). In general, the analyses revealed a great variation of mRNA expression between
sites and animals. Differences were found between different uterine health statuses, but
the variation between the sampling sites within the groups was not significant (P > 0.05).
This indicates that inflammatory processes at the end of the postpartum period can be
regarded as multi-focal or spread throughout the uterus independent from the uterine
health status.
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INTRODUCTION
Postpartum (pp) uterine disorders, such as metritis, clinical endometritis (CE), and subclinical
endometritis (SE), have negative short- and long-term impact on bovine fertility (1–3). Bacterial
infections provoke the release of pro-inflammatory factors, such as prostaglandins and cytokines,
e.g., interleukin 1A (IL1A), interleukin 1 B (IL1B), and C-X-C motif chemokine ligand 8 (CXCL8)
Pothmann et al. Multi-Site Endometrial Sampling for mRNA
(4–6). These chemoattractants play a central role in the innate
immune response to regulate the migration of immune cells,
e.g., polymorphonuclear neutrophils (PMN), which accomplish
phagocytosis in the uterine tissue (7). Detailed information
about the physiological function of pro-inflammatory factors
involved in inflammatory processes was recently reviewed by
Pascottini et al. (8).
The cytobrush (CB) technique was reported as a reliable and
accurate method for endometrial sampling and the diagnosis of
SE by determining the proportion of PMN in the smears (9–11).
It has been discussed whether a single sample is representative for
the entire endometrium and affects the accuracy of the diagnosis
of SE [reviewed by (12, 13)]. The CB technique can also be used
to evaluate the mRNA expression in the endometrial samples. An
increased mRNA expression of cytokines was found in cows with
SE and CE compared with healthy controls (14, 15). Repeated
sampling of the same cows showed no or only few intra-cow
variations of the mRNA expression of selected factors (16, 17).
The aim of the present study was to assess mRNA pattern of
transcripts involved in physiological and pathological processes,
obtained from different endometrial sites in vivo in cows
with different uterine health status. In this study, we tested
the hypothesis that on a molecular level, clinical endometritis
is characterized by inflammatory responses spread over the
entire endometrium. Furthermore, we assume that subclinical
endometritis is characterized by an inflammation of local regions




This study was approved by the institutional ethics committee
and the national authority according to §8 of Law for Animal
Experiments, Tierversuchsgesetz-TVG (BMWFW-68.205/0156-
WF/II/3b/2014) and performed at the research farm VetFarm
Kremesberg, University of Veterinary Medicine Vienna, Austria.
The herd comprised ∼80 lactating dairy cows, housed in free
stall barns with cubicles. Eighteen Simmental cows (14multipara,
four primipara, no history of Cesarean section or dystocia) were
enrolled. All cows were examined between day 28 to 34 pp
by transrectal palpation and vaginoscopy, followed by uterine
CB sampling at five pre-defined sites. Cows with purulent or
mucopurulent vaginal discharge were defined as affected with CE
(18). Subclinical endometritis was characterized by the absence
of vaginal discharge, but with ≥ 5% PMN in one of the five
endometrial smears (19). The absence of vaginal discharge and
a proportion of < 5% PMN in the cytological samples defined
the healthy control (HC) cows.
Endometrial Sampling
Five endometrial samples were collected by CB technique from
each cow in the same order of sampling, as described (13). In
brief, the CB (Gynobrush, Heinz Herenz, Hamburg, Germany)
was inserted through a metal tube (50 cm in length, 6mm inner
diameter) and forwarded under manual control to the sites in the
following order: (i) corpus uteri (CU), (ii) base of the left horn
(LHB), (iii) tip of the left horn (LHT), (iv) base of the right horn
(RHB), and (v) tip of the right horn (RHT). After retraction, the
CB was rolled onto a microscope slide and thereafter stored in
tubes at −80◦C for RNA analysis. The slides were dried, fixed,
stained (Hemacolor Merck, Darmstadt, Germany) and examined
under a microscope by using X 400 magnification (Olympus
CX21, Olympus, Tokyo, Japan). The percentage of PMN was
determined by counting 300 endometrial cells and PMN in
total (11).
Total RNA Extraction, Reverse
Transcription, and Real-Time PCR
After thawing the CB, total RNA was extracted using RNeasy
Plus Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. Quantification of total RNA was
performed by spectrophotometry (NanoDrop ND-1000 Peqlab
Biotechnology, Erlangen, Germany) at 260 nm. Quality and
integrity of the isolated total RNA was assessed using the
Bioanalyzer 2100 and the Agilent RNA 6000 Nano Kit (both
Agilent Technologies, Waldbronn, Germany). The RNA integrity
number of the isolated RNA was greater 8.0 and the OD 260/280
> 2.0. Possible genomic DNA contaminations were removed
by using DNase. Reverse transcription to generate DNA was
performed as described (16). In brief, single stranded cDNA
was generated from 100 ng total RNA per sample with the
addition of 200U RevertAid Reverse Transcriptase and 2.5µM
random hexamer primers (both Thermo Scientific, Schwerte,
Germany) in a total volume of 60 µl. To confirm the absence of
any genomic DNA or contaminations, samples without reverse
transcriptase were prepared as negative controls. The generated
DNA served as template for real-time PCR to quantify mRNA
of the selected factors in the endometrial cells. Gene transcripts,
primer sequences and further parameter used for real-time PCR
are listed in Supplementary Table 1.
Real-time PCR was conducted using the Rotor-Gene 3000
(Corbett Research, Mortlake, Australia), as described (16). In
brief, amplification of 1 µl cDNA per sample was carried
out in the presence of 0.4µM of each primer (forward and
reverse) and 5 µl 2 × SensiMix SYBR Low-ROX (Bioline,
Luckenwalde, Germany) in a total reaction volume of 10 µl.
Denaturation at 95◦C for 10min was followed by a three-
step amplification in 45 cycles: denaturation at 95◦C for 15 s,
annealing for 20 s (Supplementary Table 1), and extension at
72◦C for 30 s. Subsequently, a melting curve program (50–
99◦C) with continuous fluorescence measurement confirmed
specific amplification.
Quantification of mRNA was performed with dilution
series and comparison with standards amplified simultaneously.
Messenger RNA expression of each sample was normalized
with the succinate dehydrogenase complex flavoprotein subunit
A (SDHA) and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) real-time PCR data. Calculation of mRNA expression
of protein tyrosine phosphatase receptor type C (PTPRC;
formerly known as CD45) and carcinoembryonic antigen related
cell adhesion molecule 1 (CEACAM1; formerly known as
CD66a), prostaglandin-endoperoxide synthase 2 (PTGS2), IL1A,
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IL1B, C-X-C motif chemokine ligand 8 (C-X-C motif) ligand 8
(CXCL8; formerly known as IL8), and mucins (MUC) MUC4 and
MUC16 was performed using Rotor-Gene 6.1 software.
Statistical Analysis
Statistical analyses were performed with SPSS Statistics version
23.0 (IBM, New York, USA). Data was tested for normality
with Kolmogorov-Smirnov test. For each sample, normalized
mRNA expression for the selected factors at the five pre-defined
endometrial sites was calculated. Median, interquartile range
(IQR), mean and standard deviation (SD) of normalized mRNA
expression were calculated to describe the variation within cows
with different uterine health status. At the level of endometrial
sites, the variance of normalized mRNA expression, determined
as the coefficient of variation (CV: quotient of SD and mean)
was calculated. The normally distributed data was analyzed by
ANOVA using the CV as dependent variable and HC, SE, and
CE as factors to compare with. Scheffe test was conducted for
post hoc multiple comparisons. Normalized mRNA expression
of selected transcripts on cow-level, categorized according to
uterine health status, was shown in box plots and compared by
Kruskal-Wallis test and pairwise by Mann-Whitney-U test. The
level of significance was set at P < 0.05.
RESULTS
Seven cows were diagnosed with CE, four with SE, and sevenwere
regarded as healthy (HC). Descriptive statistics and statistical
analyses of mRNA expression at the five different endometrial
sites related to uterine health (CE, SE, HC) are presented
in Tables 1–3. Proportion of normalized mRNA expression
of selected pro-inflammatory factors from cows with different
uterine health status (SE, CE, and HC) and significant differences
are shown in Figure 1.
Endometrial mRNA Expression at the Five
Sampling Sites
Comparing the median mRNA expression at the five pre-defined
sites resulted in no differences within cows with SE, CE, and
HC cows (Kruskal-Wallis test: P > 0.05, Tables 1–3). Overall,
the high IQR indicated a great variation of mRNA expression
at all different endometrial sites, in particular in cows with CE
(Tables 1–3). Moreover, the CV of mRNA expression at the five
endometrial sites was high and revealed no differences between
the groups CE, SE, and HC (Table 4).
Endometrial mRNA Expression Related to
Uterine Health Status
Median mRNA expression of IL1A, IL1B, and CXCL8 was
increased in cows with SE and CE compared with HC cows,
whereas MUC16 mRNA expression was only increased in SE
cows compared with HC cows (P < 0.05; Figure 1). Expression
of IL1A, IL1B, and CXCL8 mRNA in SE was 27-, 17-, and 30-
fold higher than in HC cows. Expression of MUC16 mRNA was
2.6-fold higher in SE compared with HC cows. No differences
of median mRNA expression between groups were found for
PTPRC, CEACAM1, PTGS2, andMUC4 (P > 0.05).
TABLE 1 | Median, interquartile range (IQR), mean, and standard deviation (SD) of normalized mRNA expression for different pro-inflammatory factors and mucins in the
endometrium at the corpus uteri (CU), the base of the left horn (LHB), the tip of the left horn (LHT), the base of the right horn (RHB) and the tip of the right horn (RHT)
collected from seven cows with clinical endometritis (CE) on day 28 to 34 postpartum.
CE cows (n = 7) Endometrial sites
Factor LHT RHT RHB LHB CU
PTGS2 Median (IQR) 1.6 (50.1) 0.5 (209.6) 1.6 (331.6) 3.2 (21.9) 1.1 (16.6)
Mean (SD) 177.8 (437.9) 84.0 (178.3) 132.9 (265.0) 111.4 (281.7) 205.4 (535.2)
PTPRC Median (IQR) 0.7 (2.5) 1.0 (0.8) 1.5 (5.8) 0.6 (1.7) 0.6 (1.7)
Mean (SD) 1.5 (1.5) 0.6 (1.5) 2.8 (3.9) 1.1 (1.2) 1.7 (2.6)
CEACAM1 Median (IQR) 3.3 (2.8) 2.5 (9.7) 1.5 (9.4) 1.2 (4.2) 1.6 (6.1)
Mean (SD) 2.6 (5.0) 4.5 (6.5) 4.7 (6.3) 5.5 (10.8) 5.1 (8.9)
Il1A Median (IQR) 659.9 (2,237) 608.5 (26,878) 1,815 (19,737) 228.4 (3,865) 1,841 (5,871)
Mean (SD) 36,761 (95,367) 10,872 (23,531) 8,296 (15,950) 13,039 (31,750) 26,511 (65,930)
Il1B Median (IQR) 0.8 (86.3) 0.3 (147.9) 1.1 (36.0) 0.5 (40.1) 0.6 (98.8)
Mean (SD) 242.0 (578.9) 59.2 (89.9) 14.7 (25.3) 13.8 (22.7) 182.9 (440.3)
CXCL8 Median (IQR) 1.6 (377.5) 0.8 (283.0) 1.1 (171.9) 2.0 (59.6) 0.7 (6.3)
Mean (SD) 476.2 (1,034) 113.4 (214.3) 69.1 (147.8) 34.7 (65.3) 590.0 (1,557)
MUC4 Median (IQR) 41.6 (107.8) 27.4 (279.0) 35.5 (52.5) 3.3 (101.5) 47.6 (138.7)
Mean (SD) 54.4 (50.1) 118.0 (180.2) 29.6 (26.9) 36.5 (55.6) 122.0 (203.7)
MUC16 Median (IQR) 2.3 (2.5) 1.5(2.7) 0.8 (7.9) 0.9 (2.1) 3.2 (2.8)
Mean (SD) 2.3 (1.6) 1.7 (1.6) 3.8(5.6) 1.8 (1.7) 2.5 (1.3)
PTGS2, prostaglandin-endoperoxide synthase 2; PTPRC, protein tyrosine phosphatase receptor type C; CEACAM1, carcinoembryonic antigen related cell adhesion molecule 1; IL1A,
interleukin 1 alpha; IL1B, interleukin 1 beta; CXCL8, C-X-C motif chemokine ligand 8; MUC4, mucin 4; MUC16, mucin 16.
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TABLE 2 | Median, interquartile range (IQR), mean, and standard deviation (SD) of normalized mRNA expression for different pro-inflammatory factors and mucins in the
endometrium at the corpus uteri (CU), the base of the left horn (LHB), the tip of the left horn (LHT), the base of the right horn (RHB) and the tip of the right horn (RHT)
collected from four cows with subclinical endometritis (SE) on day 28 to 34 postpartum.
SE cows (n = 4) Endometrial sites
Factor LHT RHT RHB LHB CU
PTGS2 Median (IQR) 19.2 (141.0) 3.9 (3.4) 25.2 (56.8) 80.2 (554.0) 27.3 (417.9)
Mean (SD) 56.0 (85.9) 4.0 (1.8) 28.7 (30.0) 212.9 (326.0) 149.4 (262.6)
PTPRC Median (IQR) 0.6 (1.9) 2.1 (3.4) 0.4 (1.8) 0.7 (0.4) 0.9 (1.9)
Mean (SD) 1.2 (1.2) 2.1 (1.8) 1.0 (1.1) 0.7 (0.2) 1.1 (1.0)
CEACAM1 Median (IQR) 3.3 (16.4) 2.8 (8.1) 0.5 (16.2) 3.6 (24.7) 2.3 (21.0)
Mean (SD) 6.9 (9.5) 3.9 (4.4) 5.7 (10.6) 9.7 (14.8) 7.9 (12.9)
Il1A Median (IQR) 826.0 (6,414) 1.8 (5.3) 12.8 (4,446) 7.9 (14,777) 34.6 (17,190)
Mean (SD) 2,415 (3,808) 2.4 (2.9) 1,489 (2,959) 4,928 (9,846) 5,748 (11,444)
Il1B Median (IQR) 1.6 (.2) 0.3 (1.6) 1.3 (4.1) 1.8 (8.2) 5.9 (20.0)
Mean (SD) 3.3(4.7) 0.6 (0.9) 2.0 (2.2) 3.5 (4.7) 9.4 (11.1)
CXCL8 Median (IQR) 3.2 (28.6) 2.5 (56.7) 4.0 (31.0) 15.8 (27.7) 6.2 (524.1)
Mean (SD) 11.3 (17.9) 20.2 (36.8) 12.2 (19.0) 15.1 (15.6) 177.6 (346.3)
MUC4 Median (IQR) 6.1 (43.2) 98.0 (243.9) 9.6 (70.3) 12.4 (60.2) 9.2 (631.1)
Mean (SD) 17.1 (25.8) 114.7 (134.0) 26.8 (41.6) 24.9 (34.4) 213.7 (415.0)
MUC16 Median (IQR) 2.8 (3.5) 1.2 (1.6) 2.4 (5.4) 3.3 (1.8) 2.4 (2.2)
Mean (SD) 3.0 (1.8) 1.3 (0.9) 3.5 (3.1) 3.5 (0.9) 2.5 (1.1)
PTGS2, prostaglandin-endoperoxide synthase 2; PTPRC, protein tyrosine phosphatase receptor type C; CEACAM1, carcinoembryonic antigen related cell adhesion molecule 1; IL1A,
interleukin 1 alpha; IL1B, interleukin 1 beta; CXCL8, C-X-C motif chemokine ligand 8; MUC4, mucin 4; MUC16, mucin 16.
TABLE 3 | Median, interquartile range (IQR), mean, and standard deviation (SD) of normalized mRNA expression for different pro-inflammatory factors and mucins in the
endometrium at the corpus uteri (CU), the base of the left horn (LHB), the tip of the left horn (LHT), the base of the right horn (RHB) and the tip of the right horn (RHT)
collected from seven healthy cows (HC) on day 28 to 34 postpartum.
HC cows (n = 7) Endometrial sites
Factor LHT RHT RHB LHB CU
PTGS2 Median (IQR) 6.1 (10.2) 3.1 (5.3) 7.0 (8.1) 9.2 (22.2) 4.6 (17.2)
Mean (SD) 33.3 (76.0) 3.6 (3.4) 7.2 (8.1) 39.1 (78.0) 17.7 (29.9)
PTPRC Median (IQR) 0.5 (0.8) 0.6 (1.4) 0.5 (0.2) 0.6 (0.5) 0.5 (0.4)
Mean (SD) 0.8 (0.6) 0.9 (0.6) 0.5 (0.5) 0.7 (0.8) 0.3 (0.5)
CEACAM1 Median (IQR) 4.0 (11.8) 2.5 (4.2) 2.7 (13.6) 3.1 (35.8) 4.1 (10.0)
Mean (SD) 5.7 (6.4) 4.0 (5.0) 6.5 (9.0) 13.7 (17.3) 6.0 (5.4)
Il1A Median (IQR) 0.01 (1.9) 0.4 (22.4) 5.6 (206.4) 0.3 (203.3) 0.2 (0.6)
Mean (SD) 258.8 (683.8) 64.8 (160.4) 410.5 (946.9) 98.6 (185.3) 26.9 (70.6)
Il1B Median (IQR) 0.1 (0.2) 0.1 (0.6) 0.1 (0.2) 0.1 (0.2) 0.01 (0.1)
Mean (SD) 0.2 (0.2) 0.4 (0.6) 0.1 (0.2) 0.1 (0.1) 0.1 (0.1)
CXCL8 Median (IQR) 0.1 (0.2) 0.01 (0.8) 0.1 (0.2) 0.1 (0.2) 0.1 (0.2)
Mean (SD) 0.2 (0.3) 0.7 (1.3) 0.6 (1.3) 0.2 (0.3) 0.1 (0.2)
MUC4 Median (IQR) 6.5 (23.4) 11.2 (130.0) 1.2 (30.8) 15.0 (21.5) 6.6 (20.2)
Mean (SD) 19.2 (30.4) 68.1 (90.1) 31.9 (66.3) 18.2 (25.0) 24.8 (49.3)
MUC16 Median (IQR) 1.0 (5.7) 0.9 (2.3) 0.8 (1.3) 0.9 (3.5) 2.8 (4.6)
Mean (SD) 2.3 (2.8) 1.3 (1.2) 1.3 (1.7) 1.7 (2.1) 2.2 (2.4)
PTGS2, prostaglandin-endoperoxide synthase 2; PTPRC, protein tyrosine phosphatase receptor type C; CEACAM1, carcinoembryonic antigen related cell adhesion molecule 1; IL1A,
interleukin 1 alpha; IL1B, interleukin 1 beta; CXCL8, C-X-C motif chemokine ligand 8; MUC4, mucin 4; MUC16, mucin 16.
DISCUSSION
In the course of an inflammatory process, cells of the immune
system synthesize a broad range of pro-inflammatory factors.
The mRNA expression of certain cytokines and glycoproteins
are dependent on the health status of the bovine endometrium,
the stage of the estrus cycle and anatomical sections of the
uterus (15–17). This study aimed to provide new information
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FIGURE 1 | (A–D): mRNA expression of normalized (A) IL1A, (B) IL1B, (C) CXCL8 and (D) MUC16 collected from four cows (20 samples) with subclinical
endometritis (SE), seven cows (31 samples*) with clinical endometritis (CE) and seven (35 samples) healthy cows (HE). In CE, four samples were missing because of
failed cytobrush sampling. Only diagrams showing significant results of pro-inflammatory factors and mucins are presented. Different letters indicate significant
differences between groups: a:b < 0.05. The circle mean outliers and asterisks mean extreme outliers (values).
about the inflammatory response at different sites of the uterus
and for cows with different uterine health status at the end
of the postpartum period, i.e., when the regeneration of the
epithelium is supposed to be completed. Our hypothesis was
that on a molecular level, clinical endometritis is characterized
by inflammatory responses spread over the entire endometrium,
whereas subclinical endometritis is described by an inflammation
of local regions of the uterus. The results of the multi-site
comparison between the mRNA expressions of the selected
transcripts, however, did not support our hypothesis since the
variation of mRNA expression was independent from uterine
health status. In this study, we analyzed a limited number
of factors. Our selection was based on previous studies and
represented factors associated with uterine disorders. In further
research, the inflammatory response on molecular level should
be investigated including more transcripts, additional signs of
uterine inflammation as well as cow-specific factors, such as
stage of lactation, parity, and the previously pregnant and
non-pregnant uterine horns.
The mRNA expression at different uterine sites has hardly
been investigated. Gabler et al. (16) reported first information
showing no region-dependent mRNA expression for different
PGE synthases and ILs comparing the corpus uteri, the
ipsilateral, and contralateral horn from uterine tissues collected
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TABLE 4 | Oneway ANOVA of the coefficient of variation (CV) for the normalized mRNA expression of selected transcripts in five pre-defined endometrial sites obtained
from seven cows with clinical endometritis (CE), four with subclinical endometritis (SE), and seven healthy control cows (HC) on days 28 to 34 postpartum.
Factor Group Mean SD SEM CI lower bound CI upper bound P
PTGS2 CE 1.2 0.6 0.2 0.659 1.827 0.26
SE 0.94 0.2 0.1 0.693 1.192
HC 0.7 0.4 0.1 0.417 1.109
PTPRC CE 0.8 0.5 0.2 0.372 1.197 0.83
SE 0.8 0.4 0.2 0.107 1.452
HC 0.6 0.2 0.1 0.431 0.867
CEACAM1 CE 0.7 0.3 0.1 0.454 1.042 0.73
SE 0.6 0.2 0.1 0.263 0.972
HC 0.7 0.2 0.1 0.475 0.937
IL1A CE 1.1 0.6 0.2 0.552 1.670 0.82
SE 1.4 0.7 0.3 0.339 2.413
HC 1.3 0.7 0.3 0.676 1.932
IL1B CE 1.2 0.41 0.1 0.802 1.503 0.75
SE 1.2 0.7 0.4 0.105 2.373
HC 1.0 0.4 0.1 0.676 1.378
CXCL8 CE 1.3 0.4 0.2 0.929 1.752 0.60
SE 1.3 0.5 0.21 0.487 2.045
HC 1.1 0.4 0.2 0.703 1.439
MUC4 CE 0.8 0.6 0.2 0.295 1.339 0.40
SE 1.1 0.3 0.2 0.568 1.661
HC 0.7 0.5 0.2 0.220 1.162
MUC16 CE 0.6 0.3 0.1 0.339 0.877 0.94
SE 0.6 0.2 0.1 0.280 0.842
HC 0.6 0.2 0.1 0.426 0.739
Mean, standard deviation (SD), and standard error of the mean (SEM) of CV. Lower and upper bound of confidence interval (CI) and P-value of multiple comparison (Scheffe test).
PTGS2, prostaglandin-endoperoxide synthase 2; PTPRC, protein tyrosine phosphatase receptor type C; CEACAM1, carcinoembryonic antigen related cell adhesion molecule 1; IL1A,
interleukin 1 alpha; IL1B, interleukin 1 beta; CXCL8, C-X-C motif chemokine ligand 8; MUC4, mucin 4; MUC16, mucin 16.
at the abattoir. Bauersachs et al. (17) identified a couple of
genes with lower expression in the corpus uteri of healthy
heifers after slaughtering, but the majority of transcripts
were similar expressed across the uterine horns. In our
study, mRNA expression was not different, but overall, the
results indicate a high variation of mRNA expression of
selected factors at the five different sites. Interleukin 1 beta
is contributing to inflammatory processes by stimulating the
production of CXCL5 and by activating vascular endothelial
cells to promote migration of neutrophils (20, 21). C-X-
C motif chemokine ligand 8 is responsible for recruitment
of PMN (22), which may explain the higher abundance in
endometric cows.
In agreement with other studies (15, 23, 24), the mRNA
expression of IL1A, IL1B, and CXCL8 was increased in cows
showing signs of CE and SE compared with healthy control cows.
These results indicate the immune-modulating response of ILs
to infections. In the present study, the mRNA expression of
MUC16 was more abundant in SE compared with healthy cows.
In contrast, Wagener et al. (25) found higher MUC16 mRNA
expression in the follicular phase of subfertile and healthy cows.
Mucins are protective glycoproteins for epithelial tissues against
bacterial invasion (26), therefore, an upregulation in endometric
cows with SE can be expected.
This study provides some new aspects of inflammatory
reactions in the bovine endometrium on a molecular level and
contributes to our understanding of uterine pathologies. In
addition, multi-site sampling and analysis of pro-inflammatory
factors may be used to improve or validate the diagnosis
of endometritis.
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